PharMerica (PMC) Tops Q2 View; Guides FY08 Sales/EPS
More News related to PMC
- PharMerica to Present at the Credit Suisse 18th Annual Healthcare Conference
- PharMerica to Present at the Oppenheimer 20th Annual Healthcare Conference
- PharMerica (PMC) Tops Q3 EPS by 16c; Guides In-Line
- PharMerica Reports Results for the Third Quarter of 2009 and Nine Months Ended September 30, 2009
- Trading Radar for 10/29: Exxon (XOM), Motorola (MOT), Waste Management (WM) Report
More News related to Earnings
- Denison Mines (DNN) Posts Q3 Loss of $0.27, Misses Views
- RailAmerica (RA) Reports Q3 EPS of $0.08
- Western Gas Partners (WES) Posts Q3 EPS of $0.30, Beats by 3c
- Kongzhong (KONG) Posts Q3 non-GAAP EPS of $0.16, Tops by 6c
- Applied Materials (AMAT) Post Better Than Expected Profit, But To Show 1,500 Workers The Door
PharMerica Corporation (NYSE: PMC) reports Q2 EPS of $0.22, 5 cents better than the analyst estimate of $0.17. Revenues for the quarter were $486.3 million, versus the consensus of $483.10 million.
Sees FY08 EPS of $0.74-$0.83, versus the consensus of $0.80 and revs of $1.95-$1.97 billion, versus the consensus of $1.95 billion.
Related Categories
EarningsGuidance
Stocks Mentioned
+0.22Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
